Loading interface...

Pepsigard-P Suspension

Manufactured bySAF FERMION LTD
ContainsSucralfate (500 mg/5 ml) + Domperidone (5 mg/5 ml)
Description
Pepsigard-P Suspension is a combination of Sucralfate and Domperidone. It is used to treat stomach and intestinal ulcers (painful sores). It also helps to treat nausea and vomiting that may be associated with ulcers. Sucralfate works by forming a protective coating on the surface of your ulcer and helps in healing. Domperidone works by blocking a chemical substance (dopamine) in your body that is responsible for the symptoms of nausea and vomiting. Pepsigard-P Suspension may cause common side effects such as constipation and dryness in your mouth. Other less common side effects include diarrhoea, indigestion, headache, drowsiness, etc. Consult your doctor if these symptoms persist or if they become severe. Pepsigard-P Suspension should be taken exactly as advised by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Pepsigard-P Suspension should be avoided if you are allergic to it. Inform your doctor if you have heart, liver, kidney problems, or diabetes (a condition where blood sugar levels are high) before taking this medicine. Close evaluation with respect to your current medicines is necessary to avoid any undesired side effects. If you are pregnant or are breastfeeding consult your doctor before taking this medication.

Side effects

Major & minor side effects for Pepsigard-P Suspension

  • Constipation
  • Indigestion
  • Flatulence (Passing of gas)
  • Diarrhoea
  • Dry mouth
  • Drowsiness
  • Headache

Uses of Pepsigard-P Suspension

What is it prescribed for?

  • Gastrointestinal ulcers
  • Nausea and vomiting
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required by Pepsigard-P Suspension to show its action is not clinically known.
  • How long do the effects of this medicine last?
    The duration for which Pepsigard-P Suspension remains active in your body is not clinically known.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies have been reported with Pepsigard-P Suspension.
  • Can this medicine be taken during pregnancy?
    It is not known if Pepsigard-P Suspension use during pregnancy will affect your developing foetus and hence is not recommended during pregnancy unless absolutely necessary. If you are pregnant, consult your doctor.
  • Can this medicine be taken while breast-feeding?
    Pepsigard-P Suspension passes into breastmilk and may cause side effects in your infant. If you are breastfeeding, consult your doctor.

Allergy

Avoid taking Pepsigard-P Suspension if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of you face/tongue/throat), severe dizziness, breathing difficulty, etc.

Prolactinoma

Prolactinoma is a condition with a noncancerous tumor of your pituitary gland (the gland located at the base of your brain). This tumor increases the levels of a hormone called prolactin. Since Pepsigard-P Suspension may increase your prolactin levels, this medicine is not recommended if you have this condition due to the increased risk of worsening your condition.

Gastrointestinal disorders

Pepsigard-P Suspension is not recommended if you have a history of bleeding in your stomach/intestines or a blockage/tear in your intestines due to the increased risk of worsening your condition.

Heart diseases

Pepsigard-P Suspension is not recommended if you have pre-existing heart problems such as heart failure (heart is unable to pump blood properly), prolonged QT interval (an abnormal heart rhythm) due to the increased risk of worsening your condition.

Moderate to severe liver impairment

Liver impairment is a condition of reduced liver function. Pepsigard-P Suspension is not recommended due to the increased risk of worsening your condition.
Warnings for special population

Pregnancy

It is not known if Pepsigard-P Suspension use during pregnancy will affect your developing foetus and hence is not recommended during pregnancy unless absolutely necessary. If you are pregnant, consult your doctor.

Breast-feeding

Pepsigard-P Suspension passes into breastmilk and may cause side effects in your infant. If you are breastfeeding, consult your doctor.
General warnings

Other medicines

Pepsigard-P Suspension may interact with other medicines and may reduce their effectiveness. Inform your doctor about all your current medicines including any herbs or supplements before taking this medicine.

Antacids

When taking antacids along with Pepsigard-P Suspension, it is recommended to maintain a dosing gap of at least 30 minutes.

Driving or Operating machinery

Pepsigard-P Suspension may cause drowsiness. If you experience such symptoms, avoid driving vehicles or operating machines.

Missed Dose

Try not to skip a dose of Pepsigard-P Suspension. Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed one. Do not double the dose to compensate for a missed one.

Overdose

Do not take more dose than that is prescribed by your doctor. Contact your doctor in case of an overdose with Pepsigard-P Suspension.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Dolutegravir

Fluoroquinolone antibiotics

Fosphenytoin

Furosemide

Digoxin

Allopurinol

Warfarin

Digitoxin

Cabotegravir

Disease interactions

Diabetes

If you have diabetes, Pepsigard-P Suspension may increase your risk of hyperglycaemia (high blood sugar levels). Your blood sugar levels will be closely monitored and the dose of your anti-diabetic medicines may be adjusted accordingly.

Chronic kidney disease

Chronic kidney disease is a long-term condition that causes a gradual loss of kidney function. Pepsigard-P Suspension should be used with caution if you have this condition due to the increased risk of severe side effects.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Pepsigard-P Suspension on an empty stomach, at least 1 hour before your meal. Do not take more or less than the prescribed dose. Do not stop the use of this medicine without consulting your doctor as it may worsen your condition. Pepsigard-P Suspension may cause constipation. Consult your doctor before taking laxatives (medicines used to treat constipation). Pepsigard-P Suspension may increase your blood sugar levels if you have diabetes. It is recommended to regularly monitor your blood sugar levels. Pepsigard-P Suspension may causes drowsiness. Do not drive vehicles or operate machines if you experience drowsiness after taking this medicine.
Miscelleneous

To be taken on an empty stomach

To be taken as instructed by doctor

May cause sleepiness

How it works
Pepsigard-P Suspension is a combination of Sucralfate and Domperidone. Sucralfate belongs to a class of medications called protectants. It works by sticking to your damaged ulcer tissue and protects it against stomach acid and enzymes. This helps in healing your ulcer. Domperidone works by blocking dopamine, a chemical substance in your body that is responsible for the symptoms of nausea and vomiting.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Gastrointestinal agents, Antiemetics

Schedule

Schedule H

Drugs, H., 2021. Sucralfate: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 1 October 2021].

https://medlineplus.gov/druginfo/meds/a681049.html>

Kudaravalli, P. and John, S., 2021. Sucralfate. [online] Ncbi.nlm.nih.gov. Available at: < [Accessed 1 October 2021].

https://www.ncbi.nlm.nih.gov/books/NBK551527/>

Pubchem.ncbi.nlm.nih.gov. 2021. Sucralfate. [online] Available at: < [Accessed 1 October 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Sucralfate>

Medicines.org.uk. 2021. Domperidone 1mg/ml Oral Suspension - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 4 October 2021].

https://www.medicines.org.uk/emc/product/3188/smpc>

Medicines.org.uk. 2021. [online] Available at: < [Accessed 4 October 2021].

https://www.medicines.org.uk/emc/files/pil.3188.pdf>

Saffermion.com. 2021. Welcome to Saf Fermion Limited. [online] Available at: < [Accessed 4 October 2021].

http://www.saffermion.com/pepsigard-p-jr.asp>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 29 Oct 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.